ICOC/Governing Board

Return to CIRM Meetings and Events

 

MEETING NOTICE AND AGENDA
REGULAR MEETING OF THE
INDEPENDENT CITIZENS’ OVERSIGHT COMMITTEE
CALIFORNIA INSTITUTE FOR REGENERATIVE MEDICINE
Organized Pursuant To The
CALIFORNIA STEM CELL RESEARCH AND CURES ACT

Date: Thursday, December 8, 2011
Time: 9:00 AM – 5:00 PM

Main Location:
Harvey Morse Auditorium
Cedars Sinai Medical Center
8700 Beverly Blvd.
Los Angeles, CA 90048

Other Locations:
UCSF School of Medicine
513 Parnassus Avenue, Room S224
San Francisco, CA 94143

Stanford School of Medicine
Li Ka Shing Center for Learning and Knowledge/291 
Campus DriveLK3CO2 3rd Floor/MC5216/
Stanford CA 94305-5101

Audiocast:
To access the live event or archive, use this URL:
https://im.csgsystems.com/cgi-bin/confCast
Enter Conference ID# 224434 then click Go.

1. Call to Order.

2. Pledge of Allegiance.

3. Roll Call.

[Members of the Public will be invited to provide testimony before or during consideration of
each item. Makers of public comments are asked to limit their testimony to three (3) minutes.]

Reports & Discussion Items

4. Chairman’s Report.

5. President’s Report.

Action Items

6. Consideration of financial audit for Fiscal Year 2010-2011
2010/2011 Financial supplement

7. Consideration of Strategic Plan

8. Consideration of Intellectual Property Subcommittee mission statement

9. Consideration of Research Leadership Award Application

Closed session

10. Discussion of confidential intellectual property or work product, prepublication data, financial information, and confidential scientific research or data relating to application for CIRM Research Leadership Award (Health & Safety Code 125290.30(f) (3) (B) and (C))

Action Items

11. Spotlight on Disease Presentation

12. Consideration of appointment of Patient Advocate and Scientific Members of the GrantsWorking Group

13. Consideration of appointment and/or reappointment of members of the Standards Working Group
Additional appointment/reappointment document

14.Consideration of amendments to the Grants Administration Policy

15. Consideration of Bridge Funding component of Opportunity Fund

16. Consideration of External Innovation component of Opportunity Fund

17. Consideration of hPSC concept proposal

18. Consideration of resolution honoring Dr. John Sladek, former Chair of the Grants Working Group

19. Consideration of minutes from October 2011 Board meeting

Discussion items

20. Public comment. The Committee will accept public testimony on any matter under its jurisdiction that is not on the agenda, but the Committee cannot act on any such matter at this meeting.

THE ORDER OF BUSINESS MAY BE CHANGED WITHOUT NOTICE.

**NOTICE**

The California Institute for Regenerative Medicine and its Independent Citizens Oversight Committee, and any
subcommittees thereof, comply with the Americans with Disabilities Act (ADA) by ensuring that the meeting
facilities are accessible to persons with disabilities, and providing that this notice and information given to the
Members of the Committee is available to the public in appropriate alternative formats when requested. If you need
further assistance, including disability-related modifications or accommodations, you may contact Maria Bonneville
at the California Institute for Regenerative Medicine at 415-396-9100 no later than the day prior to the meeting.
Questions or requests for additional information prior to the Independent Citizens Oversight Committee meeting
may be referred to Maria Bonneville at the California Institute for Regenerative Medicine at
mbonneville@cirm.ca.gov or 415-396-9100.

 
 

 

MEETING NOTICE AND AGENDA
REGULAR MEETING OF THE
INDEPENDENT CITIZENS’ OVERSIGHT COMMITTEE
CALIFORNIA INSTITUTE FOR REGENERATIVE MEDICINE
Organized Pursuant To The
CALIFORNIA STEM CELL RESEARCH AND CURES ACT

Date: Thursday, December 8, 2011
Time: 9:00 AM – 5:00 PM

Main Location:
Harvey Morse Auditorium
Cedars Sinai Medical Center
8700 Beverly Blvd.
Los Angeles, CA 90048

Other Locations:
UCSF School of Medicine
513 Parnassus Avenue, Room S224
San Francisco, CA 94143

Stanford School of Medicine
Li Ka Shing Center for Learning and Knowledge/291 
Campus DriveLK3CO2 3rd Floor/MC5216/
Stanford CA 94305-5101

Audiocast:
To access the live event or archive, use this URL:
https://im.csgsystems.com/cgi-bin/confCast
Enter Conference ID# 224434 then click Go.

1. Call to Order.

2. Pledge of Allegiance.

3. Roll Call.

[Members of the Public will be invited to provide testimony before or during consideration of
each item. Makers of public comments are asked to limit their testimony to three (3) minutes.]

Reports & Discussion Items

4. Chairman’s Report.

5. President’s Report.

Action Items

6. Consideration of financial audit for Fiscal Year 2010-2011
2010/2011 Financial supplement

7. Consideration of Strategic Plan

8. Consideration of Intellectual Property Subcommittee mission statement

9. Consideration of Research Leadership Award Application

Closed session

10. Discussion of confidential intellectual property or work product, prepublication data, financial information, and confidential scientific research or data relating to application for CIRM Research Leadership Award (Health & Safety Code 125290.30(f) (3) (B) and (C))

Action Items

11. Spotlight on Disease Presentation

12. Consideration of appointment of Patient Advocate and Scientific Members of the GrantsWorking Group

13. Consideration of appointment and/or reappointment of members of the Standards Working Group
Additional appointment/reappointment document

14.Consideration of amendments to the Grants Administration Policy

15. Consideration of Bridge Funding component of Opportunity Fund

16. Consideration of External Innovation component of Opportunity Fund

17. Consideration of hPSC concept proposal

18. Consideration of resolution honoring Dr. John Sladek, former Chair of the Grants Working Group

19. Consideration of minutes from October 2011 Board meeting

Discussion items

20. Public comment. The Committee will accept public testimony on any matter under its jurisdiction that is not on the agenda, but the Committee cannot act on any such matter at this meeting.

THE ORDER OF BUSINESS MAY BE CHANGED WITHOUT NOTICE.

**NOTICE**

The California Institute for Regenerative Medicine and its Independent Citizens Oversight Committee, and any
subcommittees thereof, comply with the Americans with Disabilities Act (ADA) by ensuring that the meeting
facilities are accessible to persons with disabilities, and providing that this notice and information given to the
Members of the Committee is available to the public in appropriate alternative formats when requested. If you need
further assistance, including disability-related modifications or accommodations, you may contact Maria Bonneville
at the California Institute for Regenerative Medicine at 415-396-9100 no later than the day prior to the meeting.
Questions or requests for additional information prior to the Independent Citizens Oversight Committee meeting
may be referred to Maria Bonneville at the California Institute for Regenerative Medicine at
mbonneville@cirm.ca.gov or 415-396-9100.

 
 

Date Published: December 5, 2012
Last Modified: June 1, 2015